1-12 of 12
Hans Tesch
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

An Indirect Comparison of Elranatamab's Progression-Free Survival and Overall Survival from Magnetismm-3 Versus Real-World External Control Arms in Triple-Class Refractory Multiple Myeloma

Luciano Costa, Thomas W LeBlanc, Hans Tesch, Pieter Sonneveld, Ryan Kyle, Liliya Sinyavskaya, Patrick Hlavacek, Aster Meche, Jinma Ren, Alex Schepart, Didem Aydin, Guido Nador, Marco DiBonaventura
Journal: Blood
Blood (2023) 142 (Supplement 1): 6716.
https://doi.org/10.1182/blood-2023-180848
Published: 2023
Journal Articles

ELN Treatment Milestones in Chronic Myeloid Leukemia Are Prognostic for Achieving Deep Molecular Response and Treatment-Free Remission in Routine Care: Results of the German CML Registry

Katharina Kohlbrenner, Norbert Galuschek, Alice Fabarius, Marcel Reiser, Klaus Fenchel, Eva Esseling, Thomas Göhler, Ralf-Bodo Kühn, Reinhard Depenbusch, Ivo Talah Azeh, Erik Engel, Richard Hansen, Mathias Hanel, Paul Jehner, Maisun Abu-Samra, Markus Ritter, Norbert Gattermann, Henning Pelz, Stefan Fuxius, Burkhard Oswald, Gabriela M Baerlocher, Tim H. Brümmendorf, Dominik Heim, Philipp le Coutre, Andreas Burchert, Dietger Niederwieser, Hans Tesch, Wolf-Karsten Hofmann, Andreas Hochhaus, Rüdiger Hehlmann, Susanne Saussele
Journal: Blood
Blood (2023) 142 (Supplement 1): 4539.
https://doi.org/10.1182/blood-2023-180730
Published: 2023
Journal Articles

Diagnosis and Treatment of MPN in Real Life - Interim-Analysis of an Exploratory Chart Review on 960 ET and MF Patients in Germany

Andreas Schmidt, Christiane Bernhardt, Anette Fries, Kathleen Jentsch-Ulrich, Andreas Josting, Stephan Kreher, Marcel Reiser, H. Tilman Steinmetz, Hans Tesch, Bernhard Kaufmann, Uta Rager, Carl C. Crodel, Francesca Palandri, Florian H. Heidel
Journal: Blood
Blood (2022) 140 (Supplement 1): 9698–9699.
https://doi.org/10.1182/blood-2022-157980
Published: 2022
Journal Articles

Therapy in Patients with Chronic Myeloid Leukemia Outside of Clinical Trials: Results of the German CML-Registry (CML-VI)

Katharina Kohlbrenner, Norbert Galuschek, Alice Fabarius, Marcel Reiser, Klaus Fenchel, Eva Eßeling, Thomas Göhler, Thomas Geer, Reinhard Depenbusch, Ivo Talah Azeh, Erik Engel, Richard Hansen, Hans-Walter Lindemann, Jürgen Anhuf, Paul Jehner, Maisun Abu-Samra, Markus Ritter, Norbert Gattermann, Henning Pelz, Stefan Fuxius, Burkhard Oswald, Gabriela M Baerlocher, Tim H.H. Brummendorf, Dominik Heim, Philipp le Coutre, Andreas Burchert, Dietger Niederwieser, Hans Tesch, Wolf-Karsten Hofmann, Andreas Hochhaus, Rüdiger Hehlmann, Susanne Saussele
Journal: Blood
Blood (2022) 140 (Supplement 1): 947–949.
https://doi.org/10.1182/blood-2022-159412
Published: 2022
Journal Articles

Prognosis of Myelodysplastic Syndromes (MDS) in Patients in the Age of 80 Years and Older: Data from the Regular Care MDS Registry in Germany

H. Tilman Steinmetz, MD, Roja Wahdat, Burkhard Haastert, PhD, Annette Sauer, MD, Bernd Lathan, MD, Christian Lerchenmüller, MD, Hans Tesch, Professor, Ulrich Germing, Stephan Schmitz, Professor
Journal: Blood
Blood (2016) 128 (22): 4333.
https://doi.org/10.1182/blood.V128.22.4333.4333
Published: 2016
Journal Articles

Non-Interventional Study Hexafil: G-CSF Use in Accordance to Guidelines?

Hans Tesch, MD, Wolfgang Abenhardt, MD, Lutz Dietze, MD, DeLi Tilly Chang, PhD, Bertram Ottillinger, MD
Journal: Blood
Blood (2012) 120 (21): 2057.
https://doi.org/10.1182/blood.V120.21.2057.2057
Published: 2012
Journal Articles

Cognitive Effects of Once Weekly (QW) Epoetin Alfa in Anemic Patients (pts) with Hematologic Malignancies Receiving Chemotherapy (CT): Interim Results of the EPOLYM Trial.

Christian Gisselbrecht, Hans Tesch, Eric Jourdan, Giuseppe Avvisati, Costas Tsatalas, Norbert Marschner
Journal: Blood
Blood (2004) 104 (11): 2217.
https://doi.org/10.1182/blood.V104.11.2217.2217
Published: 2004
Journal Articles

Thoracic positron emission tomography using 18 F-fluorodeoxyglucose for the evaluation of residual mediastinal Hodgkin disease

Clinical Trials & Observations
Martin R. Weihrauch, Daniel Re, Klemens Scheidhauer, Sascha Ansén, Markus Dietlein, Stefanie Bischoff, Heribert Bohlen, Jürgen Wolf, Harald Schicha, Volker Diehl, Hans Tesch
Journal: Blood
Blood (2001) 98 (10): 2930–2934.
https://doi.org/10.1182/blood.V98.10.2930
Published: 2001
Journal Articles

STAT3 is constitutively activated in Hodgkin cell lines

Dieter Kube, Udo Holtick, Martina Vockerodt, Tahamtan Ahmadi, Birgit Haier, Iris Behrmann, Peter C. Heinrich, Volker Diehl, Hans Tesch
Journal: Blood
Blood (2001) 98 (3): 762–770.
https://doi.org/10.1182/blood.V98.3.762
Published: 2001
Journal Articles

Expression of AC133, a Novel Hematopoietic Precursor Antigen, on Acute Myeloid Leukemia Cells

Peter A. Horn, Hans Tesch, Peter Staib, Dieter Kube, Volker Diehl, Dimitrios Voliotis, Claudia Schoch
Journal: Blood
Blood (1999) 93 (4): 1435–1437.
https://doi.org/10.1182/blood.V93.4.1435
Published: 1999
Journal Articles

Detection of Clonal Hodgkin and Reed-Sternberg Cells With Identical Somatically Mutated and Rearranged V H Genes in Different Biopsies in Relapsed Hodgkin’s Disease

Martina Vockerodt, Marta Soares, Holger Kanzler, Ralf Küppers, Dieter Kube, Martin-Leo Hansmann, Volker Diehl, Hans Tesch
Journal: Blood
Blood (1998) 92 (8): 2899–2907.
https://doi.org/10.1182/blood.V92.8.2899
Published: 1998
Journal Articles

A Phase-I Study of an Anti-CD25 Ricin A-Chain Immunotoxin (RFT5-SMPT-dgA) in Patients With Refractory Hodgkin's Lymphoma

Andreas Engert, Volker Diehl, Roland Schnell, Andrea Radszuhn, Maria-Theresia Hatwig, Silke Drillich, Gisela Schön, Heribert Bohlen, Hans Tesch, Martin-Leo Hansmann, Stefan Barth, John Schindler, Victor Ghetie, Jonathan Uhr, Ellen Vitetta
Journal: Blood
Blood (1997) 89 (2): 403–410.
https://doi.org/10.1182/blood.V89.2.403
Published: 1997